1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Determination of plasma unbound fraction of voriconazole in patients treated with a prophylactic or a curative treatment.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Voriconazole (VOR) is a triazole antifungal used in the curative treatment of invasive fungal infections and the prophylactic treatment of opportunistic fungal infections in immunocompromised patients. It is a drug for which therapeutic drug monitoring (TDM) is highly recommended.

          Related collections

          Author and article information

          Journal
          Ther Drug Monit
          Therapeutic drug monitoring
          Ovid Technologies (Wolters Kluwer Health)
          1536-3694
          0163-4356
          Dec 2014
          : 36
          : 6
          Affiliations
          [1 ] *Laboratory of Pharmacokinetics and Clinical Toxicology, Institute of Biology, University Hospital of Toulouse; and †EA4553 Laboratory of Pharmacokinetics, Claudius-Regaud Institute, Toulouse, France.
          Article
          10.1097/FTD.0000000000000095
          24819971
          5e74f4e9-02cf-4dc1-85ae-8a4d62df6b93
          History

          Comments

          Comment on this article